Nivika Pharma

Bilypsa 4 mg Tablet contains Saroglitazar 4 mg and is used to treat diabetic dyslipidemia (high cholesterol/triglycerides in people with Type 2 Diabetes). It may also be prescribed for Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in certain patients.

• Diabetic Dyslipidemia
• High Triglycerides
• Type 2 Diabetes with abnormal lipid levels
• NAFLD (Fatty Liver Disease)
• NASH (Fatty Liver with inflammation)

Saroglitazar helps:

• Lower triglycerides and bad cholesterol (LDL)
• Improve good cholesterol (HDL)
• Improve insulin sensitivity and blood sugar control 

Mycept-S 360 mg Tablet contains Mycophenolate Sodium 360 mg, an immunosuppressant medicine used to prevent the body from rejecting a transplanted organ such as a kidney, heart, or liver. It is usually prescribed along with other anti-rejection medicines.

• Prevention of kidney transplant rejection
• Prevention of heart transplant rejection
• Prevention of liver transplant rejection
• Sometimes used in certain autoimmune conditions under specialist supervision.

Mycept-S suppresses the immune system by reducing the activity of certain white blood cells that would otherwise attack the transplanted organ.

Nivika Pharma is a pharmaceutical wholesaler offering bulk supply of high-quality, affordable medicines to retailers, hospitals, and healthcare providers.

Viraday Tablet is the generic version of Atripla and contains:

• Efavirenz 600 mg
• Emtricitabine 200 mg
• Tenofovir Disoproxil Fumarate 300 mg

• Treatment of HIV-1 infection
• Helps control HIV and improves immune system function
• Reduces the risk of HIV-related complications and progression to AIDS

The three antiviral medicines work together to stop HIV from multiplying, reducing the amount of virus in the body and helping the immune system recover. 

Apigat 2.5 mg Tablet contains Apixaban 2.5 mg, an anticoagulant (blood thinner) used to prevent and treat blood clots. It helps reduce the risk of stroke in patients with atrial fibrillation (irregular heartbeat).

• Prevention of stroke in Atrial Fibrillation (AF)
• Treatment of Deep Vein Thrombosis (DVT)
• Treatment of Pulmonary Embolism (PE)
• Prevention of blood clots after hip or knee replacement surgery
• Prevention of recurrent blood clots

Apigat contains Apixaban, which blocks Factor Xa, an important clotting factor in the blood. This reduces the formation of harmful blood clots

IPCA MMF 500 Tablet contains Mycophenolate Mofetil 500 mg, an immunosuppressant medicine used to prevent the body from rejecting a transplanted organ such as a kidney, heart, or liver. It is usually taken along with other anti-rejection medicines.

• Prevention of kidney transplant rejection
• Prevention of heart transplant rejection
• Prevention of liver transplant rejection

It suppresses the body's immune system, reducing the risk that the immune system will attack and reject the transplanted organ.

• Diarrhea
• Vomiting
• Headache
• High blood pressure
• Increased risk of infections
• Low white blood cell count

• Usually taken as prescribed by a transplant specialist.
• Swallow the tablet whole.
• Often taken on an empty stomach (1 hour before or 2 hours after meals).

• Regular blood tests may be required.
• Avoid close contact with people who have infections.
• Use sun protection, as the medicine may increase the risk of skin cancer.
• Not safe during pregnancy due to the risk of birth defects.

• Brand Name: IPCA MMF 500 Tablet
• Generic Name: Mycophenolate Mofetil
• Strength: 500 mg
• Manufacturer: Ipca Laboratories

⚠️ Important: This is a prescription-only medicine and should be used only under the supervision of a transplant or specialist doctor.